Robert Lionberger
FDA
Robert Lionberger is listed at FDA. Robert is scheduled to speak at American Academy of Dermatology Annual Meeting 2027 on 19 March 2027.
Compiled from published conference agendas; not yet confirmed by Robert. Is this you? Claim this profile.
About
Robert Lionberger, Ph.D. serves as Director of the Office of Research and Standards (ORS) in the Office of Generic Drugs (OGD). Dr. Lionberger leads OGD’s implementation of the GDUFA science and research commitments including internal research activities and external research grants and collaborations to ensure the therapeutic equivalence of generic drug products. ORS also provides pre-submission advice on complex generics through pre-ANDA meetings, product specific guidance and correspondence responses. He received his undergraduate degree from Stanford University in Chemical Engineering, and a PhD from Princeton University in Chemical Engineering. After his Ph.D., he conducted post-doctoral research in Australia in the Department of Mathematics and Statistics at the University of Melbourne. Prior to joining the FDA 20 years ago, he was an Assistant Professor of Chemical Engineering at the University of Michigan.
Upcoming
American Academy of Dermatology Annual Meeting 2027 19 March 2027 – 23 March 2027
- FDA Forum: The Dermatology Drug Product Life Cycle - IND to NDA to ANDA Speaker · 19 March 2027
Spoke alongside
People who have shared a session with Robert at events on B2DB.
- Elizabeth Rizza, MD, FAAD 1 shared session
- Markham C. Luke, MD, PhD, FAAD Physician, Reviewer, Supervisor · FDA 1 shared session
- Priyanka Ghosh, PhD 1 shared session
- Roselyn E. Epps, MD, FAAD 1 shared session